jRCT ロゴ

臨床研究等提出・公開システム

Top

Japanese

Dec. 19, 2023

April. 02, 2024

jRCT1032230520

An Uncontrolled, Open-label, Exploratory Trial Investigating Temporal Changes in Microcirculatory Dysfunction in Patients with Takotsubo Syndrome Using Pressurewire X

evaluation of microvascular dysfunction in patients with Takotsubo syndrome

Ken Kato

Chiba University Hospital

1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba 260-86 77, JAPAN

+81-43-222-7171

caua3419@chiba-u.jp

Hiroki Goto

Chiba University Hospital

1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba 260-86 77, JAPAN

+81-43-222-7171

cdca0048@chiba-u.jp

Recruiting

Dec. 19, 2023

12

Interventional

single arm study

open(masking not used)

uncontrolled control

single assignment

diagnostic purpose

This clinical trial sets two stages of selection criteria, primary registration and secondary registration, and targets patients who meet all the criteria at each stage. Primary registration is conducted for patients suspected of having Takotsubo syndrome. Secondary registration is conducted after catheter examination.

Primary Registration:

1, Adults aged 18 and over at the time of consent acquisition.
2, Patients who have received sufficient explanation about participating in this trial, have a full understanding, and have obtained written consent by their own free will or that of a proxy.
3, Patients who are hospitalized at Chiba University Hospital, or are scheduled to be hospitalized after a cardiac catheter examination.
4, Patients suspected of having Takotsubo syndrome based on primary examinations (electrocardiogram, echocardiogram, blood tests, etc.).
Secondary Registration:

1, Patients diagnosed with Takotsubo syndrome as a result of cardiac catheter examination, and who can continue to measure IMR, CFR, and CS-Lac/Ao-Lac ratio.

Patients conflicting with any of the following will not be included in this clinical trial:

1, Patients from whom consent cannot be obtained, either from themselves or a proxy.
2, Patients deemed unsuitable as subjects by the trial responsible (sub) physician.

18age old over
No limit

Both

takotsubo syndrome

To evaluate coronary artery microcirculatory resistance and coronary flow reserve changes during th
e acute and recovery phases of patients with Takotsubo syndrome using the CoroFlow system (Abbo
tt). Also, to evaluate changes in microcirculatory resistance by assessing lactate levels in blood sam
ples collected from the coronary sinus and aorta.The acetylcholine stress test is performed during t
he recovery phase to evaluate whether or not coexist coronary spasm.

takotsubo syndrome,Microvascular Angina,Coronary spasm angina

D054549

Changes over time (acute phase - after 3 months) in microvascular resistance index by pressurewireX (Abbott)

Changes over time (acute phase - after 3 months)in coronary flow reserve obtained by pressurewireX (Abbott), and the ratio of lactate levels of blood obtained from coronary
sinus and aorta over time

Clinical Research Initiation-Fund of Chiba University Hospital
Applicable
Chiba University Certified Clinical Research Review Board
1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba 260-8677, JAPAN , Chiba, Chiba

+81-43-226-2616

prc-jim@chiba-u.jp
Approval

Dec. 01, 2023

No

none

History of Changes

No Publication date
3 April. 02, 2024 (this page) Changes
2 April. 02, 2024 Detail Changes
1 Dec. 19, 2023 Detail